ReviewCancer drug resistance (Alhambra, Calif.)2019

Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer.

Logeswari Ponnusamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.